Renegade Research

They raised a very sizeable sum from patients and got funding from Balvi.

Now they just keep on attracting funding and money from patients and organisations (such as Solve M.E.) without anything to show for it?
It makes me wonder what an org like Balvi or Solve or anyone else uses to evaluate the success of projects they fund.

One would hope they would monitor projects like remission biome to see if it worked out (or even was completed) because they don’t want to just throw their money away.

But based on @Hutan’s conversations with Solve in that thread, I would say the definition of success is quite subjective.
 
Last edited:
Trish,

they are a 501 C3 nonprofit corporation in the USA since 8/2024. They have to file some financial info and a tiny bit of description of the expenditures, but it is not much. Since Solve ME/CFS initiative is their funder, I think they would be setting the factors for determining if they’re gonna keep on funding this organization or not.

Here is some info from ProPublica: https://projects.propublica.org/nonprofits/organizations/372120626
 
Recently, a website was launched for the Collaborative Sciences Institute. Their mission:
Systems biology education for clinicians treating complex chronic disease. A rigorous learning community for functional medicine doctors and chronic disease specialists ready to reason across networks, mechanisms, and lived cases.

There are three founders:

Isabel Ramirez-Burnett
CEO and founding member of Renegade Research

Dr. John Haughton, MD
Chief Medical Officer of Renegade Research

Joshua Leisk
Creator of the Born Free Protocol
 
I'm appalled to see Leisk, a fitness trainer who makes up complicated protocols and sells supplrments in such a context. Has any of his stuff been tested in a clinical trial, as i vaguely recall him saying he would get done several years ago.
 
I know I shouldn’t bother with this sort of rubbish; it just drains my energy and upsets me for no good reason. Nevertheless, I can’t help but share this post with you here.



It sums up pretty much everything that is so unprofessional about this organisation: the stoking of expectations that can directly influence trial participants, the daft and performative emotionalisation of ongoing trials, and, last but not least, the excessive overweighting of even the tiniest positive effects.
 
Tess Falor said:
I cried at my desk today.

I was reviewing applications for one of our @RenegadeRes projects, SIGNAL, which will lend the
rapeutic devices to people with ME/CFS and Long COVID.

I was working in a spreadsheet and it hit me that each row is a real person with the columns g
iving me hints of how much their lives have been affected. Many are in their 80s. Some are jus
t starting their adult lives and are bedbound. One got sick when they were 6 years old … in 19
55! So many are “very severe”, dependent on care. Triggered by infections, car accidents, envi
ronmental toxins, and more. All over the US.
I imagined my own story there: 42 years old • ME/CFS • multiple triggers • symptoms since 2006

I scrolled down… 100 rows… 200 rows… so many people… and there are tens of millions more out t
here.

Ugh. This work is heavy.

But then I felt a hint of hope. In a month I might be hearing from people in this spreadsheet
telling me that the device is helping them. I know that the devices won’t work for everyone
and won’t be a cure, but even if it just works for a few in this group, even just one, even j
ust a little, it matters.
View Original Post

I dislike dunking on people who like all of us have lost so much and who show care but no, no, no. This is not he way. This is not how you do science. This is not how you help people. Sadly so often it is the opposite.

I find it baffling that you can have years of training as an engineer and scientist and then take this approach. Helping people is a noble aim but the approach is not based in any science or engineering methodology, And I find the mixing of that with emotion and financial incentives really distasteful.

If part of your sales pitch is your education and training, your doctorate, your systems thinking and time at NASA then I think it’s fair to question this.

‘Well we built and stress tested this lander design and it worked once out of 100 times so it’s good to go to Mars’ is not something you would hear at JPL.
 



They're working with Amatica now. I believe Amatica is funding Renegade and others. Anyway, as I was saying, patients are organising things themselves because they feel let down by mainstream research and the medical establishment.

(Strangely enough, none of them seem to pay any attention to DecodeME... which is rather odd for scientists.)

It's all quite sad, really.
 
A member has asked me to post this email they received from the Signal team (the links did not copy through on the pdf):

Vielight Photobiomodulation Study Eligibility Survey (Device Loans for ME/CFS and Long COVID)
SIGNAL team <signal@renegade-research.org> To: <xxxxx>

Thu, Nov 19 at 1:36 PM
Hi xxxxxxx,

Snapshot
Eligibility survey for Vielight trial here! Due by Dec 11, 2026

Before starting survey please complete a FUNCAP assessment-free link MoCA XpressO cognitive screening-instructions

Study details, requirements, possible risk/benefit information below

In case you missed it. Solve ME webinar on SIGNAL

Our first Vielight study has been been officially approved by IRB (Institutional Review Board)! Thank you so much for your patiencein this process.

Watch the Solve ME webinar on SIGNAL to learn more about how we got started, the science behind the first two devices (Vielight photobiomodulation device and Truvaga vagus nerve stimulation), some details of the Vielight project, and a look forward for what we
plan over the next year.

ELIGIBILITY SURVEY
The eligibility survey for Vielight study is here! Before starting the survey, please complete the MoCA XpressO & FUNCAP below.
Please complete by Friday, December 11, 2026:

1. The MoCA XpressO cognitive screening Must be completed by prospective participant Click for detailed instructions

2. A recent FUNCAP score
A recent FUNCAP can be used from any platform.
Here is a free website to determine your score
May be completed by prospective participant with assistance from caregiver

3. Basic Eligibility survey (link)
The first several pages are consent documents to gather information
To minimize PEM you may complete each part on separate daysIf you are eligible after completing these steps, you will be invited to complete informed consent and enroll in this study.

Enrollment for the first Vielight study is expected to begin December 2026 and will enroll 40 participants

Study estimated to start in January 2026
If you are not eligible at this time, please be assured we will have more studies in the future.

STUDY DETAILS
The purpose of this research study is to test the effectiveness of Vielight Gamma in improving cognitive performance and cognitive functional capacity in people with ME

To be eligible for this study you must:
Be 18-65 years of age
Live in the USA & be fluent in English
Have ME/CFS prior to 2020 (not from Long Covid)
Experience Brain fog/possible Mild Cognitive Impairment determined by MoCA XpressO
Have Moderate to Very Severe ME determined by FUNCAP

Participation Requirements: Smart phone, tablet, laptop, or computer and able to use screen up to 15 minutes
Device use per titration protocol (up to 20min 6x week) ~10 weeks
Complete short daily survey (~2 minutes) ~10 weeks
Complete assessments every other/weekly (~5-15min) for ~10 weeks plus 4 weeks follow up after stopping device
Follow up surveys at 4 weeks
Return device after testing period

Compensation:
There is no cost to participants. Vielight Gamma device and return shipping will be provided
Participants will receive $0 in monetary compensation.

Possible benefits:
Cognitive impairment and cognitive functional capacity may improve as part of the study, but can not be guaranteed. However, this study may help people in the future.

Possible risks:
The ME/CFS population is known to have new and heightened sensitivities. Dose scale has been modified to titrate dose up to recommended levels for cognitive impairment by manufacturer.
Temporary symptoms of too high dosage:
HeadachePEM (particularly cognitive)

Thank you,
ME Vielight Study Team
 
Back
Top Bottom